NewsFlash »

Myeloma Experts From Ohio State University To Field Questions At The Beacon Forums Next Week – As a way of giving multiple myeloma patients an opportunity to get expert answers to their myeloma-related questions, The Myeloma Beacon has arranged for physicians from The Ohio State University’s Myeloma Clinic to answer medical questions posted to the Beacon forums during the upcoming week. The center has a number of young, enthusiastic myeloma specialists who are eager to answer forum readers’ questions. One of the experts, Dr. Craig Hofmeister, has already provided answers to a number of forum questions. Readers are encouraged to begin posting their questions to the forums.

Boehringer Ingelheim And Micromet Announce Cooperation For Experimental Multiple Myeloma Treatment – Boehringer Ingelheim and Micromet announced last week that they will collaborate on the development of BiTE antibodies for the treatment of multiple myeloma. BiTE antibodies, which were discovered by Micromet, target the body’s immune system toward tumor cells. The two companies will conduct pre-clinical studies together. Boehringer Ingelheim will be responsible for the clinical development of the treatment. For more information, please see the Boehringer Ingelheim press release.

Celebrity Michael McKean Wins $1 Million On Jeopardy! For International Myeloma Foundation – Michael McKean, a film and television show actor, writer, and director, was the champion of last week’s Jeopardy! celebrity tournament. McKean donated the grand prize of $1 million to the International Myeloma Foundation (IMF) to be used for patient and family education programs as well as multiple myeloma research. For more information, please see the IMF press release.